IL7 and acute lymphoblastic leukemia: Indeed, we observed increased cell survival of the P53/R26-Zeb2tg/tg T-ALL cell line in response to exogenous administration of IL-7, whereas only a minimal effect was observed in the control P53/R26+/+ cells (Fig. 5h).